Market Research Report : Stem Cell Research Marklet in India 2012
Upcoming SlideShare
Loading in...5
×
 

Market Research Report : Stem Cell Research Marklet in India 2012

on

  • 535 views

For the complete report, get in touch with us at : info@netscribes.com ...

For the complete report, get in touch with us at : info@netscribes.com



The stem cell research in India is in its nascent stage and is gradually on a growth path of acceptance by people. The market is still in a phase of conducting research to establish itself as one of the best therapies for the widely prevalent incurable lifestyle diseases. Awareness campaigns and doctors are playing a key role educating people and especially would-be parents about the benefits associated with preserving stem cells.

The report begins with the introduction section which offers a brief insight of the concept of stem cell therapy and banking, the conventional sources of stem cells and the current and future therapeutic solutions for the most risky diseases. It then moves to the market overview section which provides an insight of the Indian stem cell therapy market, with highlight on the market size and growth. It also covers the market size and growth prospect of the stem cell banking market in India. In addition to these, the report gives a snapshot of the current and expected stem cell banking customers.

An analysis of the drivers explains the factors for growth of the industry that include favourable regulatory environment, high patient population, stem cell application in drug development, rising consumer awareness, a rise in medical tourism and an increase in research and development expenditure to ensure stem cell therapy as a viable treatment for the numerous diseases. The key challenges include high cost of therapy, capital intensive market and high development costs of stem cell resulting in slow progress of the market.

The next section of the report provides the progressive stages that the stem cell research is undergoing and the respective business prospect for each of the stages of business involved. The report then covers the key trends that are being observed in the stem cell research. Collaborations and partnerships are becoming a trend that is helping in healthy progress of the business, investments are pouring in from government, international organizations and pharmaceutical companies, serious efforts are being undertaken to raise awareness standards regarding stem cell therapy and the move is being popularized by stem cell banks by providing easy financing opportunities for banking stem cells.

Significant developments have emerged wherein new sources of stem cells have been identified – dental stem cells and menstrual blood stem cells which have been discussed along with its benefits in comparison to cord blood stem cells.

The competition section gives overview of stem cell banks and stem cell research organizations in the country. The report highlights the features of the major players operating in the market in detail. It includes elaborate profile of the major players in the market along with their financial analysis. Porters Five Forces Analysis has been incorporated

Statistics

Views

Total Views
535
Views on SlideShare
534
Embed Views
1

Actions

Likes
0
Downloads
15
Comments
0

1 Embed 1

https://lti-examples.heroku.com 1

Accessibility

Categories

Upload Details

Uploaded via as Adobe PDF

Usage Rights

CC Attribution License

Report content

Flagged as inappropriate Flag as inappropriate
Flag as inappropriate

Select your reason for flagging this presentation as inappropriate.

Cancel
  • Full Name Full Name Comment goes here.
    Are you sure you want to
    Your message goes here
    Processing…
Post Comment
Edit your comment

Market Research Report : Stem Cell Research Marklet in India 2012 Market Research Report : Stem Cell Research Marklet in India 2012 Presentation Transcript

  • Insert Cover Image using Slide Master View Do not distortStem Cell Research – India Stem Cell Research IndiaJuly 2012
  • Executive Summary • The Stem Cell Therapy market in India was valued at INR x1 units in 20‐‐ which is expected to  reach INR x2 units approximately by 20‐‐ • The Stem Cell Banking Market was worth INR y1 units in 20‐‐ and is expected to reach INR y2 Market units  in 20‐‐ • India is projected to see a rise in number of stem cell bank and stem cell depositors in near India is projected to see a rise in number of stem cell bank and stem cell depositors in near            future Drivers: Challenges: •Favorable Regulatory Environment • High Cost of Therapy High Cost of Therapy •High Patient Population • Capital intensive nature of research is  Drivers &  •Application in Drug Development decelerating the marketChallenges •Increasing Awareness • ‘Development Costs’ of Stem Cell  •Growing Medical Tourism resulting in slow progress of the market  •Increasing Health Expenditure •Increasing Health Expenditure • Efforts to increase awareness in stem cell •Increasing partnerships Trends •Increasing investments • Easy financing opportunities in stem cell  banking Major Players Stem Cell Banks Company A, Company B, Company C, Company D, Company E, Company FCompetition Organization A, Organization B, Organization C, Organization D,  Organization A Organization B Organization C Organization D Stem Cell Research Organizations Organization E, Organization F, Organization G, Organization H STEM CELL  RESEARCH MARKET IN INDIA 2012.PPT 2
  • •Introduction•Market Overview•Drivers & Challenges•Value Chain•Market Trends M k tT d•Potential Stem Cell Sources•Competition  Stem Cell Banks  Research Organizations Research Organizations•Recent Developments•Strategic Recommendations g•Appendix STEM CELL  RESEARCH MARKET IN INDIA 2012.PPT 3
  • Stem cell banking and therapeutic application are the two key area of concern which are bridged by stem cell research Stem Cell can be the solution to a myriad of diseases like Parkinsons disease, amyotrophic lateral sclerosis, spinal  cord injury, burns, heart disease, diabetes and arthritis and also for neurological problems like autism and cerebral  palsy and is also becoming an important tool for testing potential drug toxicity Stem Cell Therapy Stem Cell Banking • It is a concept of preserving the stem cells for specific • It is an emerging therapy wherein a damaged tissue  future therapeutic uses that cannot heal itself is repaired by the use of stem cell • The extraction of cord blood stem cells take about 10–15 • Stem cells are the unspecialized blood cell that has the  minutes and is applicable to both normal and caesarean  capacity to replicate and produce its own blood cells,  deliveries platelets, red and white blood cells • The cells can be cryo‐frozen and kept stored for decades in • The “Cord Blood” is a rich source of stem cells and a  The  Cord Blood is a rich source of stem cells and a liquid nitrogen liquid nitrogen critical input for such surgical treatments • Cord blood is more like a ‘biological future health  insurance’ for the newborn baby and its future offspring’s  and siblings Public Banks Private Banks •Use not restricted •For use of family only •No remuneration collected •Facility paid for by family •Usage subject to availability •Availability guaranteedThe benefits of stem cell is manifold as the cell’s usage is not just restricted to the child but siblings or family members  can use the cells if required, after a tissue matching is done STEM CELL  RESEARCH MARKET IN INDIA 2012.PPT 4
  • Stem cell therapy market is poised to grow at a very high rate due to increasing therapeutic applicationsStem Cell Therapy Market – Overview  Market Size and Growth• The Stem Cell Therapy market in India was valued at INR units INR x1 units in 20‐‐ 80• The market is expected to reach INR x6 units x6 X% approximately by 20‐‐, growing at a CAGR of X% for 60 x5 x4 this time period x2 x3 40 x1• The stem cell research is a key factor that propels the x0 therapeutic market 20• Almost m stem cell transplants are carried out in 0 India annually that is growing gradually 20‐‐ 20‐‐ 20‐‐e 20‐‐e 20‐‐e 20‐‐e 20‐‐eStem Cell Banking Market – Overview Stem Cell Banking Market Overview Market Size and Growth Market Size and Growth• The Stem Cell Banking Market was worth INR y1 INR units units in 20‐‐ and is expected to reach INR y6 units in 10 y6 20‐‐ 8• The stem cell b k h ll banking market is expected to exhibit a k d hb Y% y5 CAGR of Y% between 20‐‐ and 20‐‐ 6 y4• Stem cell banking that was unheard of a few years 4 y3 back but has become popular in the recent past as a y2 y1 2 y0 less traumatic alternative to treat neurological diseases and as guarantee for the entire family 0 against several other diseases 20‐‐ 20‐‐ 20‐‐e 20‐‐e 20‐‐e 20‐‐e 20‐‐e STEM CELL  RESEARCH MARKET IN INDIA 2012.PPT 5
  • Drivers & Challenges – Summary  Drivers i Favorable Regulatory Environment Challenges High Patient Population High Cost of Therapy Application in Drug Development Capital Intensive Market Increasing Awareness High Development Cost Growing Medical Tourism Increasing R&D Expenditure STEM CELL  RESEARCH MARKET IN INDIA 2012.PPT 6
  • Trends – Summary  Easy financing opportunities in  Increasing Partnerships stem cell banking Key  Trends Efforts to increase awareness  Increasing Investments in stem cell STEM CELL  RESEARCH MARKET IN INDIA 2012.PPT 7
  • Private: Foreign Company – Company A (1/3) Company Information Offices and Centres – India  Company A Street ACorporate Address City B City B State C City BTel No. +91 124 7239Fax No.Fax No +91 124 4734111 +91 124 4734111Website www.CompanyAcomYear of Incorporation 2005Products and ServicesP d t dS i Head OfficeCategory Products/Services Engages in collection, isolation and  Key PeopleStem cell banking  storage of cord blood stem cells Name Designation Person A Chairman Person B Managing Director Person C Person C CEO STEM CELL  RESEARCH MARKET IN INDIA 2012.PPT 8
  • Private: Foreign Company – Company A (2/3) Financial Snapshot i i lS h Key Ratios K i y‐o‐y change  Total Income Net Profit/Loss Particulars  (2011‐10) 2011 2010 2009 2008 INR units INR units Profitability Ratios Operating Margin250 ‐20 20 Net Margin200 a Profit Before Tax Margin ‐40 Return on Equity150 d b c R4 Return on Capital Employed100 R3 Return on Working Capital ‐60 50 R2 Return on Assets R1 Return on Fixed Assets 0 ‐80 Cost Ratios 20‐‐ 20‐‐ 20‐‐ 20‐‐ Operating costs (% of Sales) Administration costs (% of  Sales)Financial Summary  Interest costs (% of Sales) Interest costs (% of Sales)• The company incurred a net loss of INR d units in FY 20‐‐, as  Liquidity Ratios Current Ratio compared to net loss of INR c units in FY 20‐‐ Cash Ratio• The company reported total income of INR R4 units in FY 20‐‐,  Leverage Ratios registering an increase of m% over FY 20‐‐ Debt to Equity Ratio Debt to Capital Ratio b i l i• The company earned an operating margin of f% in FY 20‐‐, an  Interest Coverage Ratio increase of g percentage points over FY 20‐‐ Efficiency Ratios• The company reported debt to equity ratio of d in FY 20‐‐, a  Fixed Asset Turnover decrease of h% over FY 20‐‐ Asset Turnover Current Asset Turnover Working Capital Turnover Capital Employed Turnover Improved Decline STEM CELL  RESEARCH MARKET IN INDIA 2012.PPT 9
  • Private: Foreign Company – Company A (3/3) Business HighlightsDescription  NewsOverview • It was formed as a joint venture between Company A and Company BStem Cell Banking • It provides collection facility from all major cities in India • The company was awarded the most prestigious American Association of Blood Banks  Recognitions (AABB) Accreditation STEM CELL  RESEARCH MARKET IN INDIA 2012.PPT 10
  • AppendixRatio Calculations Ratio Calculations (Operating  Current Assets / Current Operating Margin Current Ratio Income/Revenues)*100 Liabilities Net Margin (Net Profit / Revenues) *100 {(Cash & Bank Balance +  Cash Ratio Marketable Securities) / Current  (Income Before Tax / Revenues  Liabilities)} Profit Before Tax Margin *100  Total Liabilities / Shareholders  q y Debt to Equity  (Net Income / Shareholders  (N I / Sh h ld Equity  E itReturn on Equity (ROE)  Equity)*100  {Total Debt / (Shareholders  Debt to Capital Ratio EBIT / (Total Assets – Current  Equity + Total Debt)} Return on Capital (ROCE)  Liabilities)*100  Interest Coverage Ratio EBIT / Interest Expense (Net Income / Working Capital)  (N I / W ki C i l)Return on Working Capital *100 Fixed Asset Turnover Sales / Fixed Assets Return on Assets (Net Income / Total Assets)*100  Asset Turnover Sales / Total Assets Return on Fixed Assets (Net Income / Fixed Assets) *100  (Operating Expenses / Sales)  Current Asset Turnover  Sales / Current Assets Operating Costs (% of Sales) *100 Administration Costs (% of  (Administrative Expenses / Sales)  Working Capital Turnover Sales / Working Capital Sales) *100 Interest Costs (% of Sales) (Interest Expenses / Sales) *100  Capital Employed Turnover  Sales / Shareholders Equity  / STEM CELL  RESEARCH MARKET IN INDIA 2012.PPT 11
  • Thank you for the attentionThe Stem Cell Research Market – India report is part of Research on India’s Healthcare Series.For more detailed information or customized research requirements please contact:Phone: +91 33 4064 6214 91 33 4064 6214E‐Mail: sales@netscribes.comFollow us on:About NetscribesNetscribes is a knowledge‐consulting and solutions firm with clientele across the globe. The company’s expertise spans areas of investment &  g g f g p y p p fbusiness research, business & corporate intelligence, content‐management services, and knowledge‐software services. At its core lies a true value proposition that draws upon a vast knowledge base. Netscribes is a one‐stop shop designed to fulfil clients’ profitability and growth objectives.Disclaimer: This report is published for general information only. Although high standards have been used in the preparation,  Netscribes isDisclaimer: This report is published for general information only Although high standards have been used in the preparation “Netscribes” is not responsible for any loss or damage arising from use of this document. This document is the sole property of Netscribes and prior permission is required for guidelines on reproduction. STEM CELL  RESEARCH MARKET IN INDIA 2012.PPT 12